Hydrochlorothiazide and Atenolol Combination Antihypertensive Therapy: Effects of Drug Initiation Order
- 1 July 2009
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 86 (5), 533-539
- https://doi.org/10.1038/clpt.2009.101
Abstract
For combination antihypertensive therapy with thiazide diuretics and β‐blockers, the effect of the order of initiation of the drugs on the outcome has not been tested. Patients with uncomplicated hypertension were randomized to receive either hydrochlorothiazide (HCTZ) or atenolol monotherapy, followed by addition of the alternative drug. Blood pressure (BP) responses were evaluated by race and order of drug initiation. A total of 368 participants received combination therapy. Among the participants, blacks showed a greater BP‐lowering effect than whites did with HCTZ monotherapy (−13.0/−7.4 mm Hg vs. −8.0/−4.2 mm Hg, P < 0.001) but a smaller BP‐lowering effect than did whites with atenolol monotherapy (−1.1/−2.9 mm Hg vs. −9.9/−9.2 mm Hg, P < 0.0001). These differences were not evident during combination therapy. However, both groups showed greater response to HCTZ + atenolol than to atenolol + HCTZ (−19.1/−14.2 mm Hg vs. −15.6/−11.3 mm Hg, P < 0.0001). Despite optimal dosing of HCTZ + atenolol, only two‐thirds of the participants achieved BP control. In HCTZ/atenolol combination antihypertensive therapy, the order in which the drugs are initiated affects total BP lowering during the first 4–6 months of therapy. Clinical Pharmacology & Therapeutics (2009) 86 5, 533–539. doi:10.1038/clpt.2009.101This publication has 15 references indexed in Scilit:
- Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studyAmerican Heart Journal, 2009
- Metabolic effects of antihypertensive agents: role of sympathoadrenal and renin-angiotensin systemsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2006
- Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialThe Lancet, 2005
- Diuretics should continue to be one of the preferred initial therapies in the management of hypertension: the argument against.2005
- ALLHAT Debate: Diuretics Are Not Preferred, First-Line Initial Therapy for HypertensionArchives of Internal Medicine, 2004
- Are thiazide diuretics preferred as first-line therapy for hypertension? An appraisal of The Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT).Internal Medicine Journal, 2003
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacyAmerican Journal of Hypertension, 2002
- Blood pressure measuring devices: recommendations of the European Society of HypertensionBMJ, 2001
- Usefulness of home blood pressure measurements in assessing the effect of treatment in a single-blind placebo-controlled open trialJournal of Hypertension, 2001